Castle Biosciences adopts 2022 Inducement Plan for 350,000 shares to attract new employees

CASTLE BIOSCIENCES INC

Board approved 2022 Inducement Plan reserving 350,000 shares of common stock for new hires as material inducement.
Plan adopted without stockholder approval under Nasdaq Listing Rule 5635(c)(4).
Awards include nonstatutory stock options, SARs, restricted stock, RSUs, and performance-based awards.
Terms substantially similar to the company's stockholder-approved 2019 Equity Incentive Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.